13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-11, with 97 holding rows worth $2,901,979,696.
- Accession
- 0001802630-26-000005
- Filer
- CIK 1802630
- Filed
- 2026-08-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 97 entries on the cover page, a total value of $2,901,979,696 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,901,979,696 with VALUE read as dollars as filed, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 939,254 | $349,092,534 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,704,318 | $178,305,749 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 2,927,895 | $160,858,551 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 1,049,000 | $159,710,250 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 9,913,401 | $150,188,025 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 225,587 | $122,229,804 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 1,931,436 | $86,161,360 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559702 | COMMON STOCK | 1,843,504 | $72,117,876 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 867,760 | $71,833,173 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 4,393,714 | $68,849,498 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 1,459,152 | $64,917,672 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 177,517 | $59,430,916 | dollars as filed | |
| GERON CORP | 374163103 | COM | 42,808,659 | $54,795,084 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 1,029,252 | $53,927,659 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,700,000 | $49,464,000 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,911,122 | $46,257,729 | dollars as filed | |
| PROGYNY INC COM | 74340E103 | Stock | 1,602,000 | $46,185,660 | dollars as filed | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 1,064,000 | $43,655,920 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 1,465,070 | $40,098,966 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 7,309,254 | $37,861,936 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 468,922 | $37,049,527 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,168,738 | $36,032,193 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,628,039 | $35,588,933 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,465,163 | $35,544,854 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,205,000 | $34,800,400 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,550,690 | $34,456,332 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 80,000 | $33,250,400 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,654,978 | $30,583,993 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 829,810 | $30,537,008 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 515,279 | $28,443,401 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 13,063,687 | $27,303,106 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 730,907 | $25,274,764 | dollars as filed | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 10,140,951 | $24,642,511 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 520,000 | $24,185,200 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 1,003,000 | $22,647,740 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 709,000 | $22,163,340 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 10,875,000 | $22,076,250 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,179,618 | $21,999,876 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 375,572 | $21,490,230 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 254,957 | $20,965,114 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 19,955 | $18,513,650 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 1,000,000 | $18,390,000 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 761,737 | $18,342,627 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 450,889 | $18,319,620 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 3,378,378 | $18,006,755 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 267,000 | $16,116,120 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,377,981 | $15,775,171 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 246,353 | $15,754,274 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 732,144 | $14,005,915 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 419,000 | $13,793,480 | dollars as filed | |
| BIODESIX INC COM | 09075X207 | Stock | 585,958 | $13,213,353 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 147,000 | $13,050,660 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 104,629 | $10,764,232 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,000,000 | $10,190,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 33,050 | $9,949,042 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 252,000 | $9,709,560 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 90,250 | $9,622,455 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 275,000 | $9,209,750 | dollars as filed | |
| SOPHIA GENETICS SA | H82027105 | ORDINARY SHARES | 1,565,000 | $9,030,050 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 128,362 | $8,960,951 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 75,000 | $8,780,250 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 388,000 | $8,718,360 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 575,000 | $8,676,750 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 165,677 | $8,408,108 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 177,687 | $7,816,451 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 50,524 | $7,779,938 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 2,500,000 | $7,300,000 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 630,000 | $6,917,400 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 450,000 | $6,916,500 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 7,708,727 | $6,725,093 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 50,000 | $6,425,000 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 842,106 | $5,827,374 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 107,000 | $5,742,690 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 822,428 | $5,707,650 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 405,523 | $4,663,515 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 950,000 | $4,607,500 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 440,000 | $4,298,800 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,063,141 | $3,912,274 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 2,788,323 | $3,624,820 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 900,000 | $3,510,000 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 101,684 | $3,495,388 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 57,036 | $2,634,493 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 314,359 | $2,444,141 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 50,000 | $1,737,000 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 19,653 | $1,708,828 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 150,000 | $1,498,500 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 25,000 | $1,468,250 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 50,000 | $910,500 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 1,045,708 | $732,100 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 10,000 | $686,500 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 150,000 | $624,000 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 188,102 | $573,711 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 5,000 | $355,250 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 72,730 | $352,013 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 90,000 | $288,000 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 1,000 | $271,450 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 10,000 | $145,900 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-26-000005 | this filing | 2026-08-11 | acceptance time not in the bulk data set |